Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A
Kieren A. Marr(Freedom to Live), Craig Sable(Craig Technologies (United States)), Jyoti Somani(National University Hospital), Genovefa A. Papanicolaou(Memorial Sloan Kettering Cancer Center), A. Ngai(United States Military Academy), Jean Marie Arduino(United States Military Academy), C. J. Lipka(United States Military Academy), Nicholas A. Kartsonis(Merck & Co., Inc., Rahway, NJ, USA (United States)), J Chodakewitz(United States Military Academy), Ray Hachem(The University of Texas MD Anderson Cancer Center)
Cited by 117
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k